PHARMAC has announced the addition of funded Bexsero for certain special groups who are close contacts of a meningococcal disease case or who have a higher risk of meningococcal disease from 1 July 2021.
All the vaccines on the National Immunisation Schedule can now be given concurrently, immediately before or after the mRNA-COVID-19 vaccine, Comirnaty, with the exception of the shingles vaccine (Zostavax). This includes MMR, influenza, HPV (Gardasil 9), tetanus, diphteria and pertussis (Boostrix) and the meningococcal vaccines (Bexsero and Menactra). See the IMAC COVID-19 website, here, for further information.
The Ministry of Health released updated information about vaccinator training and the vaccinator processes on 6 May 2021. They advised that as part of the New Zealand COVID-19 response it is essential that all immunisation vaccinations continue to be delivered including the influenza programme and on time national immunisation programme.
The Everything you need to know about FLU 2021 booklet is availabe for downlond from the Influenza information for health professionals webpage www.influenza.org.nz. The printed copy and some Programme resources will be posted to providers as soon as possible.